Unified Trust Company, N.A. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 162 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Unified Trust Company, N.A. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$156,000
-20.8%
21,766
+2.4%
0.05%
-20.7%
Q2 2021$197,000
+4.2%
21,266
+3.9%
0.06%
-6.5%
Q1 2021$189,000
-8.3%
20,4660.0%0.06%
-47.9%
Q4 2020$206,000
-10.8%
20,466
+2.5%
0.12%
-27.4%
Q3 2020$231,000
-56.5%
19,966
+1.3%
0.16%
-59.0%
Q2 2020$531,000
+263.7%
19,7160.0%0.40%
+312.4%
Q1 2020$146,000
+124.6%
19,7160.0%0.10%
+142.5%
Q4 2019$65,000
+71.1%
19,716
+5.3%
0.04%
+60.0%
Q3 2019$38,000
-17.4%
18,716
+19.1%
0.02%
-21.9%
Q2 2019$46,000
-9.8%
15,716
+14.6%
0.03%
-15.8%
Q1 2019$51,000
-5.6%
13,7160.0%0.04%
-22.4%
Q4 2018$54,00013,7160.05%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders